Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0F8XZ
|
|||
Drug Name |
PMID30074415-Compound-20
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
METASIGNAL THERAPEUTICS INC. SUPURAN, Claudiu DEDHAR, Shoukat CARTA, Fabrizio WINUM, Jean-Yves MCDONALD, Paul C UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES CNRS - DIRE
|
|||
Structure |
Download2D MOL |
|||
Formula |
C9H6OS
|
|||
Canonical SMILES |
C1=CC=C2C(=C1)C=CC(=S)O2
|
|||
InChI |
1S/C9H6OS/c11-9-6-5-7-3-1-2-4-8(7)10-9/h1-6H
|
|||
InChIKey |
FRZDLTCXOSFHJC-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 3986-98-9
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Carbonic anhydrase (CA) | Target Info | Inhibitor | [1] |
Target's Patent Info | Carbonic anhydrase (CA) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018).Expert Opin Ther Pat. 2018 Oct;28(10):729-740. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.